[Table/Fig-4]:

Increase in zone of inhibition diameter (=5 mm) of three different patient isolate (a) in presence of CAC with respect to CAZ and CEC with respect to CTX respectively, (b) in presence of CEC with respect to CTX and (c) no change in zone of inhibition diameter when tested in presence of drug and drug-inhibitor combination disks. (a), (b) confirming ESBL phenotype, (c) non-ESBL phenotype respectively. All drug susceptibility tests were done in triplicate.